V
VNRX
Volitionrx
0.1658
-0.0066-3.83%After Hours: 0.1689 +0.0031 +1.87%19:48 04/10 EDT
OPEN/PREV CLOSE0.1738/0.1724
TODAY RANGE0.1641-0.1750
VOL3.77M
MARKET CAP26.28M
52 WEEK RANGE0.1502-0.9400
AVG VOL (3M)11.03M
% TURNOVER2.38%
TURNOVER--
P/E (TTM)-0.7585
% RANGE6.26%
EPS(TTM)-0.2186
P/E(FORWARD)-1.3264
P/B-0.6089
BVPS-0.2723
DIVIDEND--
P/S12.10
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP22.22M
SHARES OUTSTANDING158.48M
NEXT EARNINGS05/13-05/18
FREE FLOAT134.03M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·6d ago
VolitionRx Earnings Call: Breakthroughs Amid Funding Strain
Dow Jones·04/02 16:16
VolitionRX Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·04/02 16:16
VolitionRX Price Target Cut to $1.00/Share From $1.50 by HC Wainwright & Co.
TipRanks·04/02 16:11
VolitionRx price target lowered to $1 from $1.50 at H.C. Wainwright
Benzinga·04/02 16:06
HC Wainwright & Co. Maintains Buy on VolitionRX, Lowers Price Target to $1
TipRanks·04/01 21:38
VolitionRx Shareholders Approve Stock Issuance and Reverse Split
Seeking Alpha·04/01 10:33
VolitionRX reports FY results
Benzinga·03/31 20:47
VolitionRX Q4 EPS $(0.05), Inline, Sales $447.034K Miss $765.167K Estimate
PR Newswire·03/31 20:05
VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update
Seeking Alpha·03/31 12:45
VolitionRx Limited secures €2M non-dilutive funding from Belgian agencies
Dow Jones·03/31 12:44
VolitionRX Price Target Maintained With a $3.00/Share by D. Boral Capital
Dow Jones·03/31 12:44
VolitionRX Is Maintained at Buy by D. Boral Capital